GR3024870T3 - Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
GR3024870T3
GR3024870T3 GR970402515T GR970402515T GR3024870T3 GR 3024870 T3 GR3024870 T3 GR 3024870T3 GR 970402515 T GR970402515 T GR 970402515T GR 970402515 T GR970402515 T GR 970402515T GR 3024870 T3 GR3024870 T3 GR 3024870T3
Authority
GR
Greece
Prior art keywords
tetrahydropyrrolo
pyrazine
spiro
processes
preparation
Prior art date
Application number
GR970402515T
Other languages
English (en)
Inventor
Toshiyuki Negoro
Makoto Murata
Shozo Ueda
Buichi Fujitani
Yoshiyuki Ono
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of GR3024870T3 publication Critical patent/GR3024870T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
GR970402515T 1991-06-26 1997-09-26 Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same GR3024870T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03183185 1991-06-26

Publications (1)

Publication Number Publication Date
GR3024870T3 true GR3024870T3 (en) 1998-01-30

Family

ID=16131263

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402515T GR3024870T3 (en) 1991-06-26 1997-09-26 Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (21)

Country Link
US (1) US5258382A (el)
EP (1) EP0520320B1 (el)
JP (1) JP2516147B2 (el)
KR (1) KR100241196B1 (el)
CN (1) CN1034176C (el)
AT (1) ATE157980T1 (el)
AU (1) AU648901B2 (el)
CA (1) CA2071273C (el)
DE (1) DE69222096T2 (el)
DK (1) DK0520320T3 (el)
ES (1) ES2108717T3 (el)
FI (1) FI98066C (el)
GR (1) GR3024870T3 (el)
HK (1) HK1001728A1 (el)
HU (1) HU218214B (el)
IE (1) IE921891A1 (el)
MX (1) MX9203231A (el)
NO (1) NO300637B1 (el)
NZ (1) NZ243255A (el)
TW (1) TW202450B (el)
ZA (1) ZA924425B (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195455B2 (ja) * 1993-01-06 2001-08-06 ウェルファイド株式会社 キノリン−３−酢酸誘導体、その製造法と用途
JP3681082B2 (ja) * 1996-06-27 2005-08-10 住友ベークライト株式会社 イミド環含有エポキシ樹脂及びエポキシ樹脂組成物
RU2203665C2 (ru) * 1997-10-20 2003-05-10 Дайниппон Фармасьютикал Ко., Лтд. Быстрорастворяющаяся фармацевтическая композиция
JP2007246539A (ja) * 1997-10-20 2007-09-27 Dainippon Sumitomo Pharma Co Ltd 速溶性医薬組成物
JP3995414B2 (ja) * 1997-10-20 2007-10-24 大日本住友製薬株式会社 安定な医薬組成物
EP1243266A4 (en) * 1999-11-11 2007-03-07 Kyorin Seiyaku Kk SOLID PREPARATIONS FOR ORAL ADMINISTRATION
CA2393466C (en) 1999-12-21 2010-01-19 Gpi Nil Holdings, Inc. Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
WO2004043491A1 (ja) * 2002-11-14 2004-05-27 Ono Pharmaceutical Co., Ltd. 脊柱管狭窄症治療剤
CA2656921A1 (en) * 2006-07-07 2008-01-10 Dainippon Sumitomo Pharma Co., Ltd. 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylates and a process for preparing the same as well as a use of the same
JP5191385B2 (ja) * 2006-08-31 2013-05-08 大日本住友製薬株式会社 コハク酸ジエステル誘導体、その製造法および医薬製造における該誘導体の使用
US7994342B2 (en) 2006-09-20 2011-08-09 Nissan Chemical Industries, Ltd. Method for producing optically active succinimide compound
KR20090057388A (ko) * 2006-09-27 2009-06-05 닛산 가가쿠 고교 가부시키 가이샤 숙신이미드 화합물의 제조 방법
US20110190497A1 (en) * 2006-09-29 2011-08-04 Daisuke Tanaka Process for production of 2,5 dioxopyrrolidine 3 carboxylate
CN101541311B (zh) 2006-10-25 2013-01-23 大日本住友制药株式会社 不易结块的颗粒制剂
JPWO2008081860A1 (ja) * 2006-12-28 2010-04-30 大日本住友製薬株式会社 光学活性コハク酸イミド誘導体およびその製造方法ならびにその使用
WO2008136527A1 (ja) * 2007-05-08 2008-11-13 Dainippon Sumitomo Pharma Co., Ltd. 光学活性ジオキソピロリジン誘導体の精製方法
CA2690086A1 (en) * 2007-07-13 2009-01-22 Masanori Tsuno Ampa receptor antagonists and aldose reductase inhibitors for neuropathic pain
JP2011026201A (ja) * 2007-10-17 2011-02-10 Mitsubishi Tanabe Pharma Corp 光学活性ピロリル−コハク酸イミド誘導体の立体選択的な製造方法
JP5697998B2 (ja) 2009-02-06 2015-04-08 大日本住友製薬株式会社 光学活性スクシンイミド誘導体の製造方法及びその中間体
US8900830B2 (en) 2010-07-29 2014-12-02 Sumitomo Dainippon Pharma Co., Ltd. Process for producing optically active succinimide derivatives
WO2012105610A1 (ja) 2011-02-02 2012-08-09 公立大学法人名古屋市立大学 眼内血管新生及び／又は眼内血管透過性亢進を伴う疾患の予防又は治療のための医薬
US10034880B2 (en) * 2014-09-11 2018-07-31 Sumitomo Dainippon Pharma Co., Ltd. Ophthalmic suspension formulation
CN106928234A (zh) * 2017-02-07 2017-07-07 上海合全药业股份有限公司 （2‑苄基‑1,2,3,4‑四氢吡咯并[1,2‑a]吡嗪）‑4‑甲醇的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60142984A (ja) * 1983-12-28 1985-07-29 Kyorin Pharmaceut Co Ltd 新規なスピロピロリジン−２，５−ジオン誘導体およびその製造法
WO1986001107A1 (en) * 1984-08-14 1986-02-27 Pfizer Inc. Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors

Also Published As

Publication number Publication date
NO922512L (no) 1992-12-28
NO922512D0 (no) 1992-06-25
US5258382A (en) 1993-11-02
MX9203231A (es) 1993-08-01
AU648901B2 (en) 1994-05-05
CN1034176C (zh) 1997-03-05
HK1001728A1 (en) 1998-07-03
DE69222096T2 (de) 1998-01-22
TW202450B (el) 1993-03-21
IE921891A1 (en) 1992-12-30
JP2516147B2 (ja) 1996-07-10
ES2108717T3 (es) 1998-01-01
DE69222096D1 (de) 1997-10-16
HUT63424A (en) 1993-08-30
KR100241196B1 (ko) 2000-03-02
FI922848A (fi) 1992-12-27
AU1848392A (en) 1993-01-14
KR930000519A (ko) 1993-01-15
HU9202105D0 (en) 1992-10-28
NO300637B1 (no) 1997-06-30
EP0520320A3 (en) 1993-03-24
EP0520320A2 (en) 1992-12-30
DK0520320T3 (da) 1997-10-13
EP0520320B1 (en) 1997-09-10
CA2071273A1 (en) 1992-12-27
CN1068825A (zh) 1993-02-10
FI98066B (fi) 1996-12-31
JPH05186472A (ja) 1993-07-27
ZA924425B (en) 1993-03-31
ATE157980T1 (de) 1997-09-15
FI922848A0 (fi) 1992-06-18
NZ243255A (en) 1994-03-25
CA2071273C (en) 2002-08-20
FI98066C (fi) 1997-04-10
HU218214B (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
EP0520320A3 (en) Tetrahydropyrrolo 1,2-a pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharaceutical compositions containing the same
AU572252B2 (en) 5-methyl-4,5 dihydro-3(2h) pyridazinone derivatives
HUT77225A (hu) Kondenzált izoxazol-oxi- és -tio-alkil-amin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
EP1035123A4 (en) NEW HETEROCYCLIC COMPOUNDS
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
TW377352B (en) Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
EP0433679A3 (en) Pharmaceutical compositions for inhibition of maillard's reaction
CA2042113A1 (en) Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
AU1507888A (en) New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same
HUT49882A (en) Process for producing new spiro square brackets open chroman-4,4'-imidazolidine square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient
CA2042112A1 (en) N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
GR70356B (el)
AU586089B2 (en) Phosphodiesterace type 111 inhibitors having a thiadiazinone ring as part of a tricyclic structure
HK108997A (en) 1'-amino-2-(benzothiazolyl)methyl¾spiro isoquinoline-4(1H),3'-pyrrolidine¾-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors